Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

ISRN Endocrinology
Kevin C J Yuen

Abstract

Growth hormone deficiency (GHD) is a well-recognized clinical syndrome in adults. However, due to the high frequency of normal serum IGF-I levels in hypopituitary adults with GHD, it is now widely accepted that despite normal levels of total IGF-I, adults clinically suspected with GHD within the appropriate clinical setting must undergo GH provocative testing to confirm its diagnosis. Although the insulin tolerance test (ITT) is labor intensive, contraindicated in the elderly and in adults with seizure disorders and ischemic heart disease, can be unpleasant for the patient, and is potentially hazardous, this test remains the gold standard test for the biochemical demonstration of GHD in adults. In contrast, with the unavailability of the GHRH and arginine test as the alternative test to the ITT in the United States since 2008, the glucagon stimulation test (GST) has since been increasingly used in the United States because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In this paper, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future pers...Continue Reading

References

Mar 5, 1970·The New England Journal of Medicine·M L MitchellC T Sawin
Feb 1, 1995·Endocrine Reviews·H de BoerE A Van der Veen
Apr 8, 2000·European Journal of Endocrinology·G AimarettiE Ghigo
Apr 10, 2002·Clinical Endocrinology·José Manuel GómezAnna Sanmartí
Jul 20, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Helen SimpsonUNKNOWN GRS Council
Mar 11, 2004·Journal of Endocrinological Investigation·F L ConceiçãoM Vaisman
Apr 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Mark E MolitchPatricia A Stephens
Nov 11, 2006·The Journal of Pediatrics·Michael S KappyRebecca Ratliff
Jul 5, 2007·European Journal of Endocrinology·Kirstine StochholmAnders Green
Jul 5, 2007·European Journal of Endocrinology·Kazuo ChiharaUNKNOWN KP-102 Study Group
Mar 26, 2008·European Journal of Endocrinology·Kirstine StochholmClaus Højbjerg Gravholt
Aug 6, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Fernando M A GiuffridaJosé Gilberto H Vieira
Aug 18, 2009·European Journal of Endocrinology·G BrabantI Kreitschmann-Andermahr
Oct 28, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·David M CookUNKNOWN American Association of Clinical Endocrinologists
Nov 28, 2009·Arquivos brasileiros de endocrinologia e metabologia·Eduardo MicmacherFlávia Lúcia Conceição
May 24, 2011·The Journal of Clinical Endocrinology and Metabolism·Mark E MolitchUNKNOWN Endocrine Society

❮ Previous
Next ❯

Citations

Jan 18, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Jessica R WilsonJessica K Devin
Jun 4, 2018·The Journal of Clinical Endocrinology and Metabolism·Jose M GarciaKevin C J Yuen
Mar 13, 2017·Endocrine·Ana Beatriz Winter TavaresFlávia Lucia Conceição
Jul 10, 2019·International Journal of Molecular Sciences·Oratile KgosidialwaAmar Agha
May 19, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·Atil Y Kargi, George R Merriam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.